Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$62.55 USD
-3.63 (-5.49%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $62.51 -0.04 (-0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth F Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Hims & Hers Health, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical Info Systems industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
HIMS 62.55 -3.63(-5.49%)
Will HIMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HIMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HIMS
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Other News for HIMS
HIMS Stock Faces Mixed Sentiment Ahead of Earnings Report
Option traders moderately bearish in Hims and Hers Health with shares down 5.67%
Hims & Hers Health Inc (HIMS) Faces Class Action Lawsuit Over Alleged Misconduct | HIMS ...
Hims & Hers Health Earnings Preview
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?